The proposed bill, H.B. No. 2025-2026, seeks to enact sections 2317.57 and 2317.571 of the Revised Code, which focus on providing information regarding the possibility of reversing a chemical abortion. The bill defines key terms such as "chemical abortion," "health care provider," and "medical emergency," and establishes requirements for health care providers to inform women about the potential for reversing a chemical abortion before administering the second medication, misoprostol. Specifically, it mandates that providers inform women about the possibility of reversal and provide printed instructions that include a hotline and a stable website with further information. The bill also outlines civil actions that can be taken against providers who fail to comply with these requirements, as well as penalties for violations.

Additionally, the bill creates the "unborn child education and public information fund," which will be used to support the development and maintenance of the aforementioned website and hotline, as well as to produce educational materials and provide training for health care providers. The Department of Health is tasked with establishing the website and implementing a public awareness program about abortion pill reversal within 90 days of the bill's effective date. The provisions of the bill will not take effect until the Department of Health has made the required information available on its website.